β 1 -Adrenoceptor mRNA level reveals distinctions between infantile hemangioma and vascular malformations

Pediatric Research

Volumn 73, Issue 4, 2013, Pages 409-413

  Rössler, Jochen ^a   Haubold, Miriam ^b   Gilsbach, Ralf ^b   Jüttner, Eva ^c   Schmitt, Daniela ^a   Niemeyer, Charlotte Marie ^a   Hein, Lutz ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CD31 ANTIGEN; GLUCOSE TRANSPORTER 1; KI 67 ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY D2-40;

ARTICLE; CAPILLARY HEMANGIOMA; CELL PROLIFERATION; CELLS; CLINICAL ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHATIC MALFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL;

ADOLESCENT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD31; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; GENETIC MARKERS; GLUCOSE TRANSPORTER TYPE 1; HEMANGIOMA, CAPILLARY; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; KI-67 ANTIGEN; NEOPLASTIC STEM CELLS; NEOPLASTIC SYNDROMES, HEREDITARY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR MALFORMATIONS;

EID: 84875666452     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.16     Document Type: Article

References (13)

1. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51. (Pubitemid 351831393)
2. Rossler J, Wehl G, Niemeyer CM. Evaluating systemic prednisone therapy for proliferating haemangioma in infancy. Eur J Pediatr 2008;167: 813-5. (Pubitemid 351733500)
3. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010;163: 269-74.
4. Annabi B, Lachambre MP, Plouffe K, Moumdjian R, Beliveau R. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res 2009;60:438-45.
5. Hajighasemi F, Hajighasemi S. Effect of propranolol on angiogenic factors in human hematopoietic cell lines in vitro. Iran Biomed J 2009;13:223-8.
6. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 2005;22:383-406. (Pubitemid 43960991)
7. North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000;31:11-22. (Pubitemid 30054381)
8. Steven M, Kumaran N, Carachi R, Desai A, Bennet G. Haemangiomas and vascular malformations of the limb in children. Pediatr Surg Int 2007;23:565-9. (Pubitemid 46800684)
9. Greenberger S, Boscolo E, Adini I, Mulliken JB, Bischoff J. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med 2010;362:1005-13.
10. Chisholm KM, Chang KW, Truong MT, Kwok S, West RB, Heerema- McKenney AE. ®-Adrenergic receptor expression in vascular tumors. Mod Pathol 2012;25:1446-51.
11. DeGeorge BR Jr, Koch WJ. Beta blocker specificity: a building block toward personalized medicine. J Clin Invest 2007;117:86-9. (Pubitemid 46048454)
12. Takahata Y, Takarada T, Iemata M, et al. Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells. J Cell Physiol 2009;218:268-75.
13. Gilsbach R, Brede M, Beetz N, et al. Heterozygous alpha 2C-Adrenoceptordeficient mice develop heart failure after transverse aortic constriction. Cardiovasc Res 2007;75:728-37. (Pubitemid 47238738)